EXHIBIT 23.1


               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

     We consent to the incorporation by reference in the Registration  Statement
(Form S-8 No. 333-06065),  the Registration  Statement (Form S-8 No. 333-32301),
and the  Registration  Statement (Form S-8 No.  333-60343) and the  Registration
Statement (Form S-8 No. 333-42840) pertaining to the 1992 Stock Option Plan, the
1995 Equity  Incentive Plan, and the 1995  Directors'  Stock Option Plan, and in
the Registration  Statement (Form S-3 No. 33-11457),  the Registration Statement
(Form S-3 No. 333-36057),  the Registration  Statement (Form S-3 No. 333-46087),
the Registration Statement (Form S-3 No. 333-86193),  the Registration Statement
(Form S-3 No. 333-49466) and the Registration Statement (Form S-3 No. 333-64864)
of Cellegy  Pharmaceuticals,  Inc. of our report  dated  February 9, 2002,  with
respect to the  consolidated  financial  statements of Cellegy  Pharmaceuticals,
Inc.  included in the Annual Report (Form 10-K) for the year ended  December 31,
2001 filed with the Securities and Exchange Commission.




Palo Alto, California
March 7, 2002